Skip to main content
Industry News
US, European and Japanese regulators hope to ease path of new antibiotics

The US FDA, European Medicines Agency and the Japanese Pharmaceuticals and Medical Devices Agency are working on a way to allow drugmakers to conduct a single development plan for antibiotics that will be accepted by all three agencies. Regulators from the three agencies had their third meeting in October and also agreed on the importance of studying antibiotics in pediatric patients.

Full Story: